Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.

Por Mulder, N. H., Willemse, P. H., Schraffordt Koops, H., de Vries, E. G., Sleijfer, D. T.
Publicado em 1990

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

Por Mulder, N. H., de Vries, E. G., Sleijfer, D. T., Schraffordt Koops, H., Willemse, P. H.
Publicado em 1992

Palmar fasciitis and arthritis in a patient with an extraovarian adenocarcinoma of the coelomic epithelium.

Por Willemse, P H, Mulder, N H, van de Tempel, H J, Aalders, J G, Sleijfer, D T
Publicado em 1991

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

Por Mulder, N. H., van der Graaf, W. T., Willemse, P. H., Koops, H. S., de Vries, E. G., Sleijfer, D. T.
Publicado em 1994

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.

Por Sleijfer, S., Willemse, P. H., de Vries, E. G., van der Graaf, W. T., Schraffordt Koops, H., Mulder, N. H.
Publicado em 1996

Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer

Por Bos, A M E, Graaf, H de, Vries, E G E de, Piersma, H, Willemse, P H B
Publicado em 2000

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

Por Schaapveld, M, de Vries, E G E, Otter, R, de Vries, J, Dolsma, W V, Willemse, P H B
Publicado em 2005

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a fe...

Por Veldhuis, G. J., Willemse, P. H., Beijnen, J. H., Boonstra, H., Piersma, H., van der Graaf, W. T., de Vries, E. G.
Publicado em 1997

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.

Por de Graaf, H., Dolsma, W. V., Willemse, P. H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G., Mulder, N. H.
Publicado em 1997

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium

Por Mourits, M J E, Hoor, K A Ten, van der Zee, A G J, Willemse, P H B, de Vries, E G E, Hollema, H
Publicado em 2002

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

Por Gietema, J. A., de Vries, E. G., Sleijfer, D. T., Willemse, P. H., Guchelaar, H. J., Uges, D. R., Aulenbacher, P., Voegeli, R., Mulder, N. H.
Publicado em 1993

A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.

Por de Vries, E. G., Gietema, J. A., Workman, P., Scott, J. E., Crawshaw, A., Dobbs, H. J., Dennis, I., Mulder, N. H., Sleijfer, D. T., Willemse, P. H.
Publicado em 1993

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.

Por Biesma, B., Willemse, P. H., Mulder, N. H., Verschueren, R. C., Kema, I. P., de Bruijn, H. W., Postmus, P. E., Sleijfer, D. T., de Vries, E. G.
Publicado em 1992

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study

Por Joerger, M, Huitema, A D R, Huizing, M T, Willemse, P H B, de Graeff, A, Rosing, H, Schellens, J H M, Beijnen, J H, Vermorken, J B
Publicado em 2007

Ovarian cysts in women receiving tamoxifen for breast cancer

Por Mourits, M J E, Vries, E G E de, Willemse, P H B, Hoor, K A ten, Hollema, H, Sluiter, W J, Bruijn, H W A de
Publicado em 1999

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.

Por de Jong, R. S., Mulder, N. H., Uges, D. R., Kaul, S., Winograd, B., Sleijfer DTh, Groen, H. J., Willemse, P. H., van der Graaf, W. T., de Vries, E. G.
Publicado em 1997

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

Por Mourits, M J, Böckermann, I, de Vries, E G, van der Zee, A G, ten Hoor, K A, van der Graaf, W T, Sluiter, W J, Willemse, P H
Publicado em 2002

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

Por Gietema, J. A., Veldhuis, G. J., Guchelaar, H. J., Willemse, P. H., Uges, D. R., Cats, A., Boonstra, H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G.
Publicado em 1995

A phase I and pharmacokinetic study of intraperitoneal topotecan

Por Hofstra, L S, Bos, A M E, Vries, E G E de, Zee, A G J van der, Beijnen, J H, Rosing, H, Mulder, N H, Aalders, J G, Willemse, P H B
Publicado em 2001

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin

Por Jong, R S de, Mulder, N H, Uges, D R A, Sleijfer, D Th, Höppener, F J P, Groen, H J M, Willemse, P H B, Graaf, W T A van der, Vries, E G E de
Publicado em 1999